Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
Cyance is an award-winning marketing technology pioneer. Nexus is a software platform designed by the company to track the buying behaviour through billions of computers belonging to millions of businesses across the globe. This platform can track the consumed content and identifies customer interests and needs. The company's customers typically generate x3 more leads and x4 more sales. With the proceeds, Cyance will increase its marketing sales and improve product development to fund the general working capital.
days to go:
Expired
investment:
Withheld
The Urban Collective is an app that allows tenants find properties that match their lifestyles. The app allows the user to share and rate properties. They intend on using the investment to add more functionality to the app.
days to go:
Expired
investment:
£283,428
KindLink are a social network for donors and charities so donors are able to make a donation to their favourite charity and help them help other people. Donors are able to see the impact of the donations they are making by following the progress of the charity and updates for the project donated to. KindLink establishes a direct connection between donor and beneficiary to create a close and community-like feel.
days to go:
Expired
investment:
£25,045
Easily understand and manage all your insurance in one simple app, ready for the digital age. Wrisk is all about transparency and allows customers to see how much they’re currently paying for their insurance, what actions they can take to reduce their risk and purchase the insurance seamlessly from within the app. Wrisk is seeking investment to expand and cater for as many insurance needs as possible.
days to go:
Expired
investment:
£1,044,630
Rebel Energy (RE) is an energy supplier on a mission to address inequality and provide everyone with easy access to clean and affordable energy, to eventually eliminate fuel poverty. RE claims that fuel poverty led to 16,500+ cold-related deaths in the UK in 2018. RE argues that as the UK home electricity market enters a phase of growth in a post-COVID world, it will be focused on offering reliable customer service and develop strategies that help people who are struggling with their electricity bills. The company has applied for a B Corporation accreditation. RE asserts that its customer support systems are automated and can handle multiple queries simultaneously. It plans to offer a weekly direct debit payment option. RE will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£503,810
